A urinary control system for controlling urination has a first light source configured to selectively apply a first light and a second light to a bladder muscle and a second light source configured to selectively apply the first light and the second light to the urethral sphincter. A first optogene is expressed to the bladder muscle and the urethral sphincter, and a second optogene is expressed to the bladder muscle and the urethral sphincter, the first optogene contracts muscles by depolarizing membrane potential when the first light is applied, the second optogene relaxes muscles by depolarizing membrane potential when the second light is applied, and the contraction and relaxation of the bladder muscle and the urethral sphincter are achieved counteractively via photostimulation by the first light and the second light, respectively, so as to control urination.

A real-time imaging method that provides ultrasonic imaging and optoacoustic imaging coregistered through application of the same hand-held probe to generate and detect ultrasonic and optoacoustic signals. These signals are digitized, processed and used to reconstruct anatomical maps superimposed with maps of two functional parameters of blood hemoglobin index and blood oxygenation index. The blood hemoglobin index represents blood hemoglobin concentration changes in the areas of diagnostic interest relative to the background blood concentration. The blood oxygenation index represents blood oxygenation changes in the areas of diagnostic interest relative to the background level of blood oxygenation. These coregistered maps can be used to noninvasively differentiate malignant tumors from benign lumps and cysts.

This disclosure relates generally to bio-signal detection, and more particularly to method and system for non-contact bio-signal detection using ultrasound signals. In an embodiment, the method includes acquiring an in-phase I(t) baseband signal and a quadrature Q(t) baseband signal associated with an ultrasound signal directed from the sensor assembly towards the target. Magnitude and phase signals are calculated from the in-phase and quadrature baseband signals, and are filtered by passing through a band pass filter associated with a predefined frequency range to obtain filtered magnitude and phase signals. Fast Fourier Transformation (FFT) of the filtered magnitude and phase signals is performed to identify frequency of dominant peaks of spectrum of the magnitude and phase signals in the ultrasound signal. Value of the bio-signal associated with the target is determined based on weighted values of the frequency of the dominant peaks of the magnitude and phase signals.

An ultrasonic diagnostic device according to an embodiment includes processing circuitry. The processing circuitry estimates a health state on the basis of a measurement value measured using ultrasonic image data. The processing circuitry determines an additional examination used to diagnose the health state, on the basis of the estimated health state. The processing circuitry outputs information indicative of the health state and the additional examination.

Provided is a non-invasive system and method for determining a fuel value for a target muscle and potentially at least one indicator muscle. The method includes receiving an ultrasound scan of a target muscle; evaluating at least a portion of the ultrasound scan to determine fuel value within the target muscle; recording the determined fuel value for the muscle as an element of a data set for the muscle; evaluating the fuel data set to determine a value range; and in response to the range being at least above a pre-determined threshold, establishing a target score for the muscle as based on an upper portion of the value range. The method may be repeated to identify ranges for a plurality of muscles, the muscle with the greatest range being identified as an indicator muscle. Based on these findings the muscles estimated fuel level, fuel rating and energy status may be determined. An associated system is also disclosed.

Provided is a bladder monitoring apparatus including: an ultrasonic sensor module including an ultrasonic sensor configured to transmit an ultrasonic wave toward a front wall of a bladder and receive the reflected ultrasonic wave; a control module configured to measure a passage time interval, calculate distance information, and calculate a volume of the bladder from the distance information and configuration information; and an output module configured to output the bladder volume calculated by the control module.

The embodiments herein provide a system for calibration-free cuff-less evaluation of blood pressure. The system includes an ultrasound-based arterial compliance probes and a controller unit connected to the said probe. The ultrasound transducers are configured to measure the change in arterial dimensions, pulse wave velocity, and other character traits of an arterial segment over continuous cardiac cycle, which is then used to evaluate blood pressure parameters without any calibration procedure using dedicated mathematical models. The pressure sensor/force sensor/bio-potential transducers/accelerometric sensors are configured to measure a pressure acting on a skin surface at a measurement site, an internal arterial transmural pressure level, an applied pressure or a hold-down pressure on the skin surface or an arterial site, biopotential and/or plethysmograph signal, arterial vibrations acting on the measurement site as a function of the arterial pressure and the mechanical characteristics and/or a function of the applied/hold-down pressure and/or function of external factors.

The invention provides a method for monitoring or predicting the onset or progression of a disease or pathological condition and/or a response to treatment in an infant vertebrate animal subject, wherein said method uses unfocused ultrasound pulses to determine a characteristic of blood flow within the brain of the subject and said characteristic or the profile of said characteristic over time is indicative or predictive of the disease or pathological condition or response to treatment, or variation in said characteristic or the profile of said characteristic over time is indicative or predictive of the disease or pathological condition, or indicative or predictive of a change in the disease or pathological condition or response to treatment.

A system and method include storage of an echo signal power spectrum of a reference phantom for a fundamental frequency band and an echo signal power spectrum of the reference phantom for a harmonic frequency band, acquisition of an echo signal power spectrum of a region of tissue for the fundamental frequency band and an echo signal power spectrum of the region of tissue for the harmonic frequency band, determination of a first backscatter coefficient based on the echo signal power spectrum of the region of tissue for the fundamental frequency band and the echo signal power spectrum of the reference phantom for the fundamental frequency band, determination of a second backscatter coefficient based on the echo signal power spectrum of the region of tissue for the harmonic frequency band and the echo signal power spectrum of the reference phantom for the harmonic frequency band, and determination of a non-linearity of the region of tissue based on the first backscatter coefficient and the second backscatter coefficient.

The application discloses the use of an aqueous composition comprising a thickener, and an antiseptic compound or a pharmaceutical acceptable salt thereof as an ultrasonic couplant spray. An ultrasonic couplant spray comprising starch, and an antiseptic compound or a pharmaceutical acceptable salt thereof is also disclosed. Furthermore, the present application relates to a kit comprising a composition according to the present application and spray device.